Barclays Maintains an 'Overweight' on Aetna (AET); Aetna Management Meetings: Recipe for Success
Tweet
Share
E-mailGet Alerts AET Hot Sheet
Price: $212.70 --0%
Rating Summary:
10 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 1
Rating Summary:
10 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 1
Join SI Premium – FREE
Barclays maintains an 'Overweight' on Aetna (NYSE: AET) price target of $54.00.
Barclays analyst says, "Broader Observations: 1) As noted on the second quarter conference call, there are several headwinds and tailwinds for earnings into 2012, which we believe will likely net to growth in 2012 EPS. 2) The preoccupation around 2012 guidance continues to pressure valuations for Aetna relative to its peers. 3) Aetna's margins are consistent with historical trends and its peers, which bolsters the case for the sustainability of current profit levels."
"Meeting Notes: 1) Our meeting began with CFO Zubretsky, with the discussion focused predominantly on strategy, cost trends, and rebates. 2) Next, we spoke with CEO Bertolini about the company's outlook on health reform and provider negotiations. 3) Lastly, we spoke with Jeff Emerson about provider network management and medical cost analytics."
For more ratings news on Aetna click here and for the rating history of Aetna click here.
Shares of Aetna closed at $39.95 yesterday.
Barclays analyst says, "Broader Observations: 1) As noted on the second quarter conference call, there are several headwinds and tailwinds for earnings into 2012, which we believe will likely net to growth in 2012 EPS. 2) The preoccupation around 2012 guidance continues to pressure valuations for Aetna relative to its peers. 3) Aetna's margins are consistent with historical trends and its peers, which bolsters the case for the sustainability of current profit levels."
"Meeting Notes: 1) Our meeting began with CFO Zubretsky, with the discussion focused predominantly on strategy, cost trends, and rebates. 2) Next, we spoke with CEO Bertolini about the company's outlook on health reform and provider negotiations. 3) Lastly, we spoke with Jeff Emerson about provider network management and medical cost analytics."
For more ratings news on Aetna click here and for the rating history of Aetna click here.
Shares of Aetna closed at $39.95 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Amundi surges as on bigger-than-expected profit, record AUM
- Alphabet, Microsoft earnings; PCE data ahead - what's moving markets
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Barclays, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
